Skip to main content
ImmuneCited

Iron Pediatric Immune Support

C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。

Iron supplementation in deficient children may help restore lymphocyte and neutrophil function. However, excess iron may feed pathogens and worsen infections. Supplementation should be guided by documented deficiency status.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Dpediatric\u002Dimmune\u002Dsupport'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Iron supplementation in deficient children may help restore lymphocyte and neutrophil function. However, excess iron may feed pathogens and worsen infections. Supplementation should be guided by documented deficiency status.

Key Study Findings

Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Systematic Review and Meta-Analysis n=7014
Trace Elements and Risk of Immune-Mediated Skin Disease: A Systematic Review and Meta-analysis.
Dose: None vs: Placebo 効果: Standardized mean differences reported for each element and disease combination (specific values not None
In Vitro
Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia.
Dose: None vs: Minoxidil Outcome: Hair regeneration in AGA mice 効果: None None

対象集団: AGA mouse model

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 効果: None None

対象集団: Children with inflammatory bowel disease (review)

Other
Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis.
Dose: None vs: Uncoated EcN and UC model mice Outcome: UC inflammation and probiotic intestinal retention 効果: None None

対象集団: Obese C57 mice with DSS-induced UC

Review
Frontal Fibrosing Alopecia in Men: A Review of the Literature.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Review of frontal fibrosing alopecia in men

Key Statistics

5

研究数

400

参加者数

Positive

C

グレード

Referenced Papers

Journal of clinical … 2025 1 件の引用
The Cochrane database … 2024 1 件の引用
Clinical reviews in … 2021 304 件の引用
Dermatitis : contact, … 2019 7 件の引用
World journal of … 2016 238 件の引用
Deutsches Arzteblatt international 2016 99 件の引用
The Cochrane database … 2015 147 件の引用
Der Internist 2015
European journal of … 2012 225 件の引用
Inflammatory bowel diseases 2012 224 件の引用
Pharmacoepidemiology and drug … 2009 22 件の引用
The Israel Medical … 2008 61 件の引用
American journal of … 2007 61 件の引用
Premenstrual syndrome. Systematic Review
BMJ clinical evidence 2007
Cardiovascular research 2006 42 件の引用
Journal of pediatric … 2006 7 件の引用
The British journal … 2002 358 件の引用
American journal of … 1999 226 件の引用
Dermatologic clinics 1998 121 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
8-18 mg/day
deficiency:
Per medical guidance based on ferritin levels

上限量: 45 mg/day (elemental iron)

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
None -- Mixed 7014
None -- Positive --
None -- Neutral --
None -- Positive --
None -- Mixed --
Disease-modifying agents (tolvaptan, etc.) -- Positive --
None -- Positive --

推奨摂取タイミング: On empty stomach with vitamin C for best absorption; avoid with calcium, coffee, or tea

Safety & Side Effects

報告されている副作用

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

既知の相互作用

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors and H2 blockers (reduce absorption)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

耐容上限摂取量: 45 mg/day (elemental iron)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Iron help with Pediatric Immune Support?
Based on 5 studies with 400 participants, there is limited but promising evidence that Iron may support Pediatric Immune Support management. Our evidence grade is C (Some Evidence).
How much Iron should I take for Pediatric Immune Support?
Studies have used various dosages. A commonly studied range is 8-18 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Iron?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Iron and Pediatric Immune Support?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

に関する他の成分: Pediatric Immune Support

References

  1. [1] Zheng Xing et al.. Acta Biomater. 2025. Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia. doi:10.1016/j.actbio.2025.05.039 PubMed
  2. [2] Yozahandy A Abarca et al.. Cureus. 2025. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities. doi:10.7759/cureus.78298 PubMed
  3. [3] Tiziana Galeazzi et al.. Nutrients. 2025. Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do? doi:10.3390/nu17091425 PubMed
  4. [4] Xie Chengfeng et al.. Colloids Surf B Biointerfaces. 2025. Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis. doi:10.1016/j.colsurfb.2025.115035 PubMed
  5. [5] Ana Melián-Olivera et al.. J Clin Med. 2025. Frontal Fibrosing Alopecia in Men: A Review of the Literature. doi:10.3390/jcm14061914 PubMed
  6. [6] Xinyi Shao et al.. Nutr Rev. 2025. Trace Elements and Risk of Immune-Mediated Skin Disease: A Systematic Review and Meta-analysis. doi:10.1093/nutrit/nuaf015 PubMed
  7. [7] Jiayang Zhang et al.. J Pineal Res. 2024. Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice. doi:10.1111/jpi.12964 PubMed
  8. [8] Xuefei Zhang et al.. Int J Nanomedicine. 2024. Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. doi:10.2147/IJN.S477820 PubMed
  9. [9] Kitty St Pierre et al.. Cochrane Database Syst Rev. 2024. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. doi:10.1002/14651858.CD010294.pub3 PubMed
  10. [10] Sule Goksin. North Clin Istanb. 2022. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. doi:10.14744/nci.2022.78790 PubMed
  11. [11] Cheng Zhou et al.. Clin Rev Allergy Immunol. 2021. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management. doi:10.1007/s12016-021-08883-0 PubMed
  12. [12] Eva Jover et al.. Biomedicines. 2021. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. doi:10.3390/biomedicines9060639 PubMed
  13. [13] Eva Hadadi et al.. Endocr Relat Cancer. 2021. Role of circadian rhythm disorders on EMT and tumour-immune interactions in endocrine-related cancers. doi:10.1530/ERC-20-0390 PubMed
  14. [14] Olla A Khalifa et al.. BMC Vet Res. 2021. The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels of the growth-related genes in … doi:10.1186/s12917-021-02963-1 PubMed
  15. [15] Dimitrios T Papadimitriou et al.. World J Clin Pediatr. 2021. Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review. doi:10.5409/wjcp.v10.i6.192 PubMed
  16. [16] Rasika Ranaweerage et al.. BMC Nephrol. 2021. Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review. doi:10.1186/s12882-021-02371-5 PubMed
  17. [17] M N Chang et al.. J Dairy Sci. 2020. Effects of different types of zinc supplement on the growth, incidence of diarrhea, immune function, and rectal microbiota of newborn … doi:10.3168/jds.2019-17610 PubMed
  18. [18] Sandeep K Riar et al.. J Clin Sleep Med. 2019. Restless Legs Syndrome in Chronic Kidney Disease: Is Iron or Inflammatory Status To Blame? doi:10.5664/jcsm.8028 PubMed
  19. [19] Aleksi J Hendricks et al.. Dermatitis. 2019. Clinical Pearls on Sleep Management in Atopic Dermatitis. doi:10.1097/DER.0000000000000523 PubMed
  20. [20] Stergios A Polyzos et al.. Diabetes Obes Metab. 2017. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and … doi:10.1111/dom.12989 PubMed
  21. [21] Danuta Owczarek et al.. World J Gastroenterol. 2016. Diet and nutritional factors in inflammatory bowel diseases. doi:10.3748/wjg.v22.i3.895 PubMed
  22. [22] Hans Wolff et al.. Dtsch Arztebl Int. 2016. The Diagnosis and Treatment of Hair and Scalp Diseases. doi:10.3238/arztebl.2016.0377 PubMed
  23. [23] Wolfgang Kruis et al.. Dig Dis. 2016. Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn's Disease: Substitute or Not? doi:10.1159/000443012 PubMed
  24. [24] Gwang Seong Choi et al.. Ann Dermatol. 2016. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia. doi:10.5021/ad.2016.28.4.444 PubMed
  25. [25] Mariè van der Merwe et al.. J Sports Med (Hindawi Publ Corp). 2016. The Influence of Methylsulfonylmethane on Inflammation-Associated Cytokine Release before and following Strenuous Exercise. doi:10.1155/2016/7498359 PubMed
  26. [26] Zhe Qu et al.. Neuromolecular Med. 2016. Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration. doi:10.1007/s12017-016-8410-1 PubMed
  27. [27] Mahsa Salehi et al.. Cochrane Database Syst Rev. 2015. Interventions for central serous chorioretinopathy: a network meta-analysis. doi:10.1002/14651858.CD011841.pub2 PubMed
  28. [28] H Wolff. Internist (Berl). 2015. [Drug treatment of alopecia]. doi:10.1007/s00108-015-3763-3 PubMed
  29. [29] Robert E Click. J Immunol Methods. 2014. Review: 2-mercaptoethanol alteration of in vitro immune functions of species other than murine. doi:10.1016/j.jim.2013.11.007 PubMed
  30. [30] Priya Batra et al.. Int J Med Mushrooms. 2013. Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. doi:10.1615/intjmedmushr.v15.i2.20 PubMed
  31. [31] Nils Hovdenak et al.. Eur J Obstet Gynecol Reprod Biol. 2012. Influence of mineral and vitamin supplements on pregnancy outcome. doi:10.1016/j.ejogrb.2012.06.020 PubMed
  32. [32] Caroline Hwang et al.. Inflamm Bowel Dis. 2012. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. doi:10.1002/ibd.22906 PubMed
  33. [33] Leonard B Weinstock et al.. Sleep Med Rev. 2012. Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. doi:10.1016/j.smrv.2011.09.003 PubMed
  34. [34] Sonja Y Hess et al.. Food Nutr Bull. 2009. Effects of maternal zinc supplementation on pregnancy and lactation outcomes. doi:10.1177/15648265090301S105 PubMed
  35. [35] Jen-Tzer Gau et al.. Pharmacoepidemiol Drug Saf. 2009. Uses of proton pump inhibitors and serum potassium levels. doi:10.1002/pds.1795 PubMed
  36. [36] Courtney I Jarvis et al.. Ann Pharmacother. 2008. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. doi:10.1345/aph.1K673 PubMed
  37. [37] Gisele Zandman-Goddard et al.. Isr Med Assoc J. 2008. Hyperferritinemia in autoimmunity. PubMed
  38. [38] Rajiv Agarwal. Am J Nephrol. 2007. Nonhematological benefits of iron. doi:10.1159/000107927 PubMed
  39. [39] Irene Kwan et al.. BMJ Clin Evid. 2007. Premenstrual syndrome. PubMed
  40. [40] Yao Sun et al.. Cardiovasc Res. 2006. Oxidative stress in aldosteronism. doi:10.1016/j.cardiores.2006.03.007 PubMed
  41. [41] Veronica Franco et al.. Clin Exp Pharmacol Physiol. 2006. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice. doi:10.1111/j.1440-1681.2006.04434.x PubMed
  42. [42] Sabine Strassburg et al.. Heart Fail Rev. 2006. Metabolic and immunologic derangements in cardiac cachexia: where to from here? doi:10.1007/s10741-006-9193-5 PubMed
  43. [43] Faith Claman et al.. J Pediatr Health Care. 2006. Premenstrual syndrome and premenstrual dysphoric disorder in adolescence. doi:10.1016/j.pedhc.2006.06.001 PubMed
  44. [44] Philip C Calder et al.. Br J Nutr. 2002. The immune system: a target for functional foods? doi:10.1079/BJN2002682 PubMed
  45. [45] T B Klepser et al.. Am J Health Syst Pharm. 1999. Unsafe and potentially safe herbal therapies. doi:10.1093/ajhp/56.2.125 PubMed
  46. [46] J Shapiro et al.. Dermatol Clin. 1998. Hair regrowth. Therapeutic agents. doi:10.1016/s0733-8635(05)70017-6 PubMed
  47. [47] J Tanaka et al.. Glia. 1997. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。